PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

NCT00276523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: PEG-interferon alfa-2b
PROCEDURE: Conventional surgery
PROCEDURE: Neoadjuvant therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]